St. Clair Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Sell
2,700
-25
-0.9% -$10K 0.28% 44
2026
Q2
$987K Sell
2,725
-25
-0.9% -$8.56K 0.25% 47
2026
Q1
$968K Sell
2,750
-50
-2% -$17.8K 0.26% 52
2025
Q4
$916K Hold
2,800
– – 0.24% 50
2025
Q3
$790K Hold
2,800
– – 0.21% 52
2025
Q2
$782K Hold
2,800
– – 0.2% 50
2025
Q1
$872K Hold
2,800
– – 0.24% 49
2024
Q4
$730K Hold
2,800
– – 0.21% 51
2024
Q3
$902K Hold
2,800
– – 0.26% 48
2024
Q2
$875K Hold
2,800
– – 0.28% 47
2024
Q1
$796K Hold
2,800
– – 0.26% 48
2023
Q4
$806K Hold
2,800
– – 0.28% 51
2023
Q3
$753K Hold
2,800
– – 0.3% 48
2023
Q2
$622K Hold
2,800
– – 0.24% 51
2023
Q1
$677K Buy
2,800
+1,300
+87% +$319K 0.3% 46
2022
Q4
$394K Buy
+1,500
New +$402K 0.25% 40
2021
Q1
– Sell
-989
Closed -$227K – 42
2020
Q4
$227K Buy
+989
New +$228K 0.21% 41

Other funds holding AMGN

St. Clair Advisors's AMGN Position: Q3 2026 in Review

St. Clair Advisors reduced its Amgen (AMGN) stake by 0.92% in Q3 2026, selling an estimated $10K and leaving 2,700 shares worth $1.14M. The position accounts for 0.28% of the portfolio, ranked #44.

St. Clair Advisors first reported a position in AMGN in Q4 2020 and has held it in 17 quarters since. 1,057 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • St. Clair Advisors held 2,700 shares of Amgen worth $1.14M as of Q3 2026.
  • St. Clair Advisors sold 25 Amgen shares in Q3 2026, an estimated $10K.
  • Amgen made up 0.28% of St. Clair Advisors's portfolio in Q3 2026, its #44 holding.
  • St. Clair Advisors first reported a position in Amgen in Q4 2020 and has held it in 17 quarters since.
  • 1,057 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on St. Clair Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.